Blood group O attributes to prolonged progression-free survival, overall survival, and 5-year survival in isocitrate dehydrogenase-wildtype glioblastoma patients with MGMT promoter methylation

Wiewrodt, Rainer; Kloss, Maren; Jost-Engl, Johanna; Troschel, Fabian M.; Troschel, Benjamin O.; Eich, Hans Theodor; Thomas, Christian; Lemcke, Lars; Stummer, Walter; Wiewrodt, Dorothee

Research article (journal) | Peer reviewed

Details about the publication

JournalNeuro-Oncology Advances (Neurooncol Adv)
Volume7
Issue1
StatusPublished
Release year2025
DOI10.1093/noajnl/vdaf037
KeywordsABO blood group; glioblastoma; long-term survivors; MGMT promoter methylation; prognosis

Authors from the University of Münster

Troschel, Fabian Martin
Clinic for Radiotherapy